Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Teleflex ( (TFX) ).
On February 23, 2026, Teleflex’s board approved a multi‑year restructuring tied to its planned strategic divestitures, aiming to realign its global organization and supply chain, cut stranded costs and rationalize capital assets, largely through workforce reductions. The program, expected to be substantially complete by mid‑2028, carries estimated restructuring and related charges of $31 million to $37 million, mostly cash outlays, and is projected to deliver annual pre‑tax savings of $48 million to $52 million once fully implemented, beginning to benefit results in 2026.
The company reported 2025 revenue from continuing operations of $1.99 billion, up more than 17% year on year, with adjusted EPS also improving, and issued 2026 guidance that builds in $90 million of stranded costs while excluding anticipated offsets from transition and manufacturing services tied to the divested units. Management framed the restructuring and divestitures as part of a broader portfolio transformation, with the two planned divestiture deals expected to close in the second half of 2026 and provide after‑tax proceeds earmarked largely for share repurchases and debt reduction, positioning Teleflex to enhance profitability and long‑term shareholder value after the transition period.
The most recent analyst rating on (TFX) stock is a Hold with a $116.00 price target. To see the full list of analyst forecasts on Teleflex stock, see the TFX Stock Forecast page.
Spark’s Take on TFX Stock
According to Spark, TipRanks’ AI Analyst, TFX is a Neutral.
The score is driven primarily by mixed financial performance—solid revenue growth and low leverage, offset by weak profitability and declining free cash flow growth. Technicals add pressure with the stock trading below major moving averages and a low RSI. Earnings-call guidance provides some support, while corporate events are a net mixed factor due to portfolio-sale/buyback positives versus leadership and execution risks. Valuation is constrained by the negative P/E and only modest dividend yield.
To see Spark’s full report on TFX stock, click here.
More about Teleflex
Teleflex Incorporated, based in Wayne, Pa., is a medical technologies company focused on vascular, interventional and surgical product categories. Following the classification of its Acute Care, Interventional Urology and OEM units as discontinued operations in late 2025, the company is repositioning around a more streamlined portfolio centered on higher-growth, higher-margin continuing operations.
Average Trading Volume: 908,917
Technical Sentiment Signal: Sell
Current Market Cap: $4.96B
See more insights into TFX stock on TipRanks’ Stock Analysis page.